Inovio Pharmaceuticals Inc (NASDAQ: INO): Stock That Needs Special Handling
The Vanguard Group, Inc. recently announced the acquisition of new stake in Inovio Pharmaceuticals Inc (NASDAQ:INO). The institutional investor has increased its shareholding in the Healthcare company by 0.03% to 19.98 million shares with purchase of 6949.0 shares. This fresh investment now brings its stake to 7.32% valued currently at $10.19 million. Currently, there are […]
Inovio Pharmaceuticals Inc (NASDAQ: INO) Hogging The Spotlight Today
The Vanguard Group, Inc. recently announced the acquisition of new stake in Inovio Pharmaceuticals Inc (NASDAQ:INO). The institutional investor has increased its shareholding in the Healthcare company by 0.03% to 19.98 million shares with purchase of 6949.0 shares. This fresh investment now brings its stake to 7.32% valued currently at $10.19 million. With over 11.18 […]
Inovio Pharmaceuticals Inc (NASDAQ: INO) Has Another Chance To Impress You
The Vanguard Group, Inc. recently announced the acquisition of new stake in Inovio Pharmaceuticals Inc (NASDAQ:INO). The institutional investor has increased its shareholding in the Healthcare company by 0.03% to 19.98 million shares with purchase of 6949.0 shares. This fresh investment now brings its stake to 7.32% valued currently at $7.87 million. With over 18.0 […]
Value Hunters: Look To Inovio Pharmaceuticals Inc (INO)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Inovio Pharmaceuticals Inc (NASDAQ:INO). The institutional investor has increased its shareholding in the Healthcare company by 0.03% to 19.98 million shares with purchase of 6949.0 shares. This fresh investment now brings its stake to 7.32% valued currently at $7.87 million. With over 5.8 […]
